<DOC>
	<DOC>NCT00370981</DOC>
	<brief_summary>The purpose of this study is to evaluate pagoclone in the treatment of premature ejaculation.</brief_summary>
	<brief_title>Exploratory Study of Pagoclone in Men With Premature Ejaculation.</brief_title>
	<detailed_description>The primary objective of this study is to evaluate the effect of 3 dose levels of pagoclone (0.15 mg, 0.30 mg, and 0.60 mg) versus placebo on intravaginal ejaculation latency time (IELT) male patients with primary premature ejaculation.</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>A male regularly experiencing premature ejaculation 18 to 55 yrs old In a Stable relationship with one woman for at least 6 months</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>investigational drug</keyword>
	<keyword>ejaculation</keyword>
</DOC>